NCT02588404 2024-12-10The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer PatientSir Mortimer B. Davis - Jewish General HospitalWithdrawn
NCT04585932 2021-01-20Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART StudyM.D. Anderson Cancer CenterPhase 2 Withdrawn